
News|Articles|September 3, 2026
SPECTRUM: Early Clinical Data and Practice Experience From Global Real-World Study of Intravitreal Aflibercept (EYLEA®, Bayer AG) 8mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Advertisement
SPECTRUM: Early Clinical Data and Practice Experience From Global Real-World Study of Intravitreal Aflibercept (EYLEA®, Bayer AG) 8mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Presentation highlights from the Association for Research in Vision and Ophthalmology (ARVO) 2026 annual meeting
Advertisement
Related Content
Advertisement

Latest CME
Advertisement
Advertisement










